Table 1.
Clinical characteristics of 65 patients analysed in this study
| Clinical parameter | n (%) |
|---|---|
| Age (years) | |
| Mean | 61 |
| Range | 47–74 |
| Gender | |
| Male | 59 (90.7) |
| Female | 6 (9.2) |
| Histology | |
| Squamous | 59 (90.7) |
| Adenocarcinoma | 4 (6.1) |
| Poorly differentiated carcinoma | 2 (3.0) |
| Location of newly diagnosed tumor | 36 (52.3) |
| Cervical | 2 (3.0) |
| Upper thoracic | 4 (6.1) |
| Middle thoracic | 16 (24.6) |
| Lower thoracic | 10 (15.3) |
| Synchronous multiple primary | 2 (3.0) |
| ECOGa score | |
| 0–1 | 59 (90.7) |
| 2 | 6 (9.2) |
| Stage (UICCb 6th edition) | |
| Newly diagnosed | 34 (52.3) |
| II | 2 (3.0) |
| III | 10 (15.3) |
| IV | 22 (33.8) |
| Postoperative LNMc | 31 (47.6) |
| Planned dose of radiation | |
| 61.2 Gy | 45 (69.2) |
| 50.4 Gy | 20 (30.7) |
aEastern Cooperative Oncology Group
bUnion for International Cancer Control
cLymph node metastasis